J
Jessica K Dyson
Researcher at Newcastle University
Publications - 78
Citations - 3245
Jessica K Dyson is an academic researcher from Newcastle University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 60 publications receiving 2365 citations. Previous affiliations of Jessica K Dyson include Freeman Hospital & Newcastle upon Tyne Hospitals NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica K Dyson,B Jaques,Dipankar Chattopadyhay,R. Lochan,Janine Graham,Debasish Das,Tahira Aslam,I Patanwala,Sameer Gaggar,Michael Cole,K Sumpter,Stephen Stewart,John Rose,Mark Hudson,Derek Manas,Helen L. Reeves,Helen L. Reeves +16 more
TL;DR: HCC related mortality is increasing, with typical patients being elderly with metabolic risk factors, but older patients with co-morbidities can do well, managed, within a specialist multidisciplinary team if their cancer is detected pre-symptomatically.
Journal ArticleDOI
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
TL;DR: A pragmatic approach to diagnosis and staging of NAFLD is discussed so that patients at the highest risk of liver-related complications can be identified.
Journal ArticleDOI
Primary sclerosing cholangitis
TL;DR: Achlioptas et al. as mentioned in this paper reported that primary sclerosing cholangitis is associated with increased malignancy risk and surveillance strategies for early CHolangiocarcinoma detection are limited.
Journal ArticleDOI
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines
Gideon M. Hirschfield,Jessica K Dyson,Graeme J.M. Alexander,Graeme J.M. Alexander,Michael H. Chapman,Jane Collier,Stefan G. Hübscher,Imran Patanwala,Imran Patanwala,Stephen P. Pereira,Collette Thain,Douglas Thorburn,Douglas Thorburn,Dina Tiniakos,Martine Walmsley,George Webster,David Jones +16 more
TL;DR: PBC is most prevalent in women and those over the age of 50, but a spectrum of disease is recognised in adult patients globally; male sex, younger age at onset and advanced disease at presentation are baseline predictors of poorer outcome.
Journal ArticleDOI
Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
TL;DR: There is insufficient evidence currently to support an increased frequency of surveillance for patients diagnosed with IBD at a younger age, so evidence-based guidelines advise surveillance colonoscopy for patients with colitis 8 to 10 years after diagnosis, with the interval for further surveillance guided by risk factors.